共 111 条
[93]
Synergistic association of elevated serum free fatty acid and glucose levels with large arterial stiffness in a general population: The Nagahama Study
[J].
METABOLISM-CLINICAL AND EXPERIMENTAL,
2016, 65 (01)
:66-72
[94]
Differential effects of GLP-1 receptor agonist on foam cell formation in monocytes between non-obese and obese subjects
[J].
METABOLISM-CLINICAL AND EXPERIMENTAL,
2016, 65 (02)
:1-11
[95]
Follistatin and activins in polycystic ovary syndrome: Relationship to metabolic and hormonal markers
[J].
METABOLISM-CLINICAL AND EXPERIMENTAL,
2013, 62 (10)
:1394-1400
[96]
Impaired insulin action in the liver, but not in adipose tissue or muscle, is a distinct metabolic feature of impaired fasting glucose in obese humans
[J].
METABOLISM-CLINICAL AND EXPERIMENTAL,
2016, 65 (05)
:757-763
[97]
Energy replacement diminishes the effect of exercise on postprandial lipemia in boys
[J].
METABOLISM-CLINICAL AND EXPERIMENTAL,
2016, 65 (04)
:496-506
[99]
(R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors
[J].
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,
2008, 325 (01)
:175-182
[100]
Ciliary neurotrophic factor upregulates follistatin and Pak1, causes overexpression of muscle differentiation related genes and downregulation of established atrophy mediators in skeletal muscle
[J].
METABOLISM-CLINICAL AND EXPERIMENTAL,
2016, 65 (06)
:915-925